These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 15757663
1. Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif. Burger-Kentischer A, Finkelmeier D, Thiele M, Schmucker J, Geiger G, Tovar GE, Bernhagen J. FEBS Lett; 2005 Mar 14; 579(7):1693-701. PubMed ID: 15757663 [Abstract] [Full Text] [Related]
2. Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell. Li Y, Lu C, Xing G, Zhu Y, He F. Exp Cell Res; 2004 Nov 01; 300(2):379-87. PubMed ID: 15475002 [Abstract] [Full Text] [Related]
3. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J. Nature; 2000 Nov 09; 408(6809):211-6. PubMed ID: 11089976 [Abstract] [Full Text] [Related]
4. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J. Cell Signal; 2006 May 09; 18(5):688-703. PubMed ID: 16122907 [Abstract] [Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Lüscher B, Bernhagen J. Oncogene; 2007 Aug 02; 26(35):5046-59. PubMed ID: 17310986 [Abstract] [Full Text] [Related]
6. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1. Hwang CY, Ryu YS, Chung MS, Kim KD, Park SS, Chae SK, Chae HZ, Kwon KS. Oncogene; 2004 Nov 25; 23(55):8868-75. PubMed ID: 15480426 [Abstract] [Full Text] [Related]
7. JAB1 enhances HAND2 transcriptional activity by regulating HAND2 DNA binding. Dai YS, Hao J, Bonin C, Morikawa Y, Cserjesi P. J Neurosci Res; 2004 Jun 01; 76(5):613-22. PubMed ID: 15139020 [Abstract] [Full Text] [Related]
8. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Tanaka Y, Kanai F, Ichimura T, Tateishi K, Asaoka Y, Guleng B, Jazag A, Ohta M, Imamura J, Ikenoue T, Ijichi H, Kawabe T, Isobe T, Omata M. Oncogene; 2006 Jan 26; 25(4):633-42. PubMed ID: 16247477 [Abstract] [Full Text] [Related]
9. The crystal structure of the human Mov34 MPN domain reveals a metal-free dimer. Sanches M, Alves BS, Zanchin NI, Guimarães BG. J Mol Biol; 2007 Jul 27; 370(5):846-55. PubMed ID: 17559875 [Abstract] [Full Text] [Related]
10. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Cope GA, Suh GS, Aravind L, Schwarz SE, Zipursky SL, Koonin EV, Deshaies RJ. Science; 2002 Oct 18; 298(5593):608-11. PubMed ID: 12183637 [Abstract] [Full Text] [Related]
11. Characterization of the human ortholog of Mov34 reveals eight N-terminal residues important for MPN domain stability. Alves BS, Oyama S, Gozzo FC, Sanches M, Guimarães BG, Zanchin NI. Biochem Biophys Res Commun; 2006 Sep 01; 347(3):608-15. PubMed ID: 16842755 [Abstract] [Full Text] [Related]
12. CSN5/Jab1 controls multiple events in the mammalian cell cycle. Yoshida A, Yoneda-Kato N, Panattoni M, Pardi R, Kato JY. FEBS Lett; 2010 Nov 19; 584(22):4545-52. PubMed ID: 20974137 [Abstract] [Full Text] [Related]
13. Structure of the Jab1/MPN domain and its implications for proteasome function. Tran HJ, Allen MD, Löwe J, Bycroft M. Biochemistry; 2003 Oct 07; 42(39):11460-5. PubMed ID: 14516197 [Abstract] [Full Text] [Related]
14. Macrophage migration inhibitory factor does not modulate co-activation of androgen receptor by Jab1/CSN5. Berndt K, Kim M, Meinhardt A, Klug J. Mol Cell Biochem; 2008 Jan 07; 307(1-2):265-71. PubMed ID: 17786542 [Abstract] [Full Text] [Related]
16. Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity. Wang H, Sun X, Luo Y, Lin Z, Wu J. FEBS Lett; 2006 Oct 30; 580(25):6015-21. PubMed ID: 17052710 [Abstract] [Full Text] [Related]
17. Interaction between glucose-regulated destruction domain of DNA topoisomerase IIalpha and MPN domain of Jab1/CSN5. Yun J, Tomida A, Andoh T, Tsuruo T. J Biol Chem; 2004 Jul 23; 279(30):31296-303. PubMed ID: 15126503 [Abstract] [Full Text] [Related]
18. JAB1/CSN5 interacts with the GAL4 DNA binding domain: a note of caution about two-hybrid interactions. Nordgård O, Dahle Ø, Andersen TØ, Gabrielsen OS. Biochimie; 2001 Oct 23; 83(10):969-71. PubMed ID: 11728635 [Abstract] [Full Text] [Related]
19. Domain architecture of the p62 subunit from the human transcription/repair factor TFIIH deduced by limited proteolysis and mass spectrometry analysis. Jawhari A, Boussert S, Lamour V, Atkinson RA, Kieffer B, Poch O, Potier N, van Dorsselaer A, Moras D, Poterszman A. Biochemistry; 2004 Nov 16; 43(45):14420-30. PubMed ID: 15533047 [Abstract] [Full Text] [Related]
20. Crystal structure of the human CSN6 MPN domain. Ma XL, Xu M, Jiang T. Biochem Biophys Res Commun; 2014 Oct 10; 453(1):25-30. PubMed ID: 25242525 [Abstract] [Full Text] [Related] Page: [Next] [New Search]